Compare
NAVs as of 20 Aug 2026
ICICI Prudential CRISIL-IBX AAA Bond Financial Services Index -Dec 2026 FundDirectICICI Prudential NASDAQ 100 Index FundDirectMotilal Oswal S&P 500 Index FundDirectUTI Nifty 500 Value 50 Index FundDirect4 of 4 funds
Comparing the maximum of 4. Replace which fund?
Growth of ₹100 (rebased over the selected window)
Common period 28 Jan 2025 – 14 Nov 2025, limited by ICICI Prudential CRISIL-IBX AAA Bond Financial Services Index -Dec 2026 Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | ICICI Prudential CRISIL-IBX AAA Bond Financial Services Index -Dec 2026 Fund | ICICI Prudential NASDAQ 100 Index Fund | Motilal Oswal S&P 500 Index Fund | UTI Nifty 500 Value 50 Index Fund | Nasdaq 100 | S&P 500 | Nifty 500 |
|---|---|---|---|---|---|---|---|
| 28 Jan 2025 | ₹100.00 | ₹100.00 | ₹100.00 | ₹100.00 | ₹100.00 | ₹100.00 | ₹100.00 |
| 21 Feb 2025 | ₹100.51 | ₹100.84 | ₹99.25 | ₹100.80 | ₹100.70 | ₹99.10 | ₹98.88 |
| 17 Mar 2025 | ₹100.88 | ₹92.63 | ₹93.88 | ₹99.96 | ₹92.31 | ₹93.53 | ₹96.96 |
| 11 Apr 2025 | ₹102.19 | ₹86.71 | ₹88.00 | ₹101.96 | ₹87.08 | ₹88.39 | ₹99.18 |
| 05 May 2025 | ₹102.85 | ₹90.56 | ₹90.77 | ₹107.93 | ₹93.03 | ₹93.12 | ₹106.07 |
| 29 May 2025 | ₹103.45 | ₹98.37 | ₹96.33 | ₹110.55 | ₹99.54 | ₹97.44 | ₹109.26 |
| 22 Jun 2025 | ₹103.89 | ₹100.89 | ₹98.60 | ₹109.79 | ₹100.76 | ₹98.35 | ₹110.11 |
| 16 Jul 2025 | ₹104.53 | ₹105.84 | ₹102.63 | ₹113.80 | ₹106.73 | ₹103.23 | ₹112.18 |
| 09 Aug 2025 | ₹104.91 | ₹111.25 | ₹106.70 | ₹108.73 | ₹110.01 | ₹105.30 | ₹107.26 |
| 03 Sep 2025 | ₹105.27 | ₹110.93 | ₹108.29 | ₹111.82 | ₹109.09 | ₹106.27 | ₹109.27 |
| 27 Sep 2025 | ₹105.69 | ₹116.91 | ₹112.44 | ₹112.91 | ₹114.17 | ₹109.49 | ₹108.55 |
| 21 Oct 2025 | ₹106.19 | ₹118.65 | ₹112.94 | ₹117.06 | ₹117.07 | ₹111.00 | ₹113.55 |
| 14 Nov 2025 | ₹106.64 | ₹119.30 | ₹114.02 | ₹121.63 | ₹116.52 | ₹110.98 | ₹113.91 |
| Metric | ICICI Prudential · Direct NAV ₹10.67 Moderate risk Unrated | ICICI Prudential · Direct NAV ₹24.30 Very High risk ★★★★☆ | Motilal Oswal · Direct NAV ₹33.75 Very High risk ★★★★☆ | UTI · Direct NAV ₹22.19 Very High risk ★★★★☆ | Category median Index Funds · 375 funds |
|---|---|---|---|---|---|
| — | +37.86%Best in row | +31.67% | +14.41% | +5.66% | |
| — | +31.72%Best in row | +26.53% | +25.30% | +8.82% | |
| — | — | +17.87% | — | +9.15% | |
| — | +19.99% | +21.56% | +27.94%Best in row | +7.67% | |
| +7.53% | +29.23%Best in row | +23.81% | +15.66% | — | |
| — | +26.37% | +17.89% | +28.43%Best in row | +12.67% | |
| — | — | +17.93% | — | +13.64% | |
| Risk | |||||
| — | 21.35% | 15.43%Best in row | 20.81% | 13.97% | |
| — | 1.18 | 1.30Best in row | 0.90 | 0.24 | |
| — | 1.75 | 1.92Best in row | 1.20 | 0.36 | |
| -0.15%Best in row | -30.04% | -19.91% | -22.63% | -16.12% | |
| — | Nasdaq 100 | S&P 500 | Nifty 500 | — | |
| — | +5.10% | +4.83% | +11.51%Best in row | +0.84% | |
| — | 0.99 | 1.02 | 1.14 | 1.00 | |
| — | 109.7% | 114.0% | 139.8%Best in row | 102.2% | |
| — | 89.3% | 89.5% | 90.5% | 97.2% | |
| 0.15%Best in row | 0.63% | 0.62% | 0.80% | 0.36% | |
| ₹16.62Cr | ₹3,348Cr | ₹4,500Cr | ₹729.68Cr | ₹177.09Cr | |
| Up to 0.25% | None | 1.00% | None | — | |
| — | ₹100 | ₹500 | ₹500 | — | |
| ₹2.03K | ₹1.00K | ₹500 | ₹1.00K | — | |
| — | 16% | 1% | 44% | 35% | |
| Darshil Dedhia | Sharmila D'silva | Rakesh Shetty | Sharwan Kumar Goyal | — | |
| 28 Jan 2025 | 19 Oct 2021 | 29 Apr 2020 | 12 May 2023 | — | |
| — | — | — | 50 | — | |
| — | — | — | 48.8% | — | |
| 3.5% | 0.1% | 0.5% | 0.1% | — | |
3 rows carry the same value for every fund — show
- 10Y return (CAGR)
- —
- 10Y rolling avg
- —
- Lock-in
- None
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.